|
Volume 270,
Number 12,
Issue of March 24, 1995 pp. 6476-6481
©1995 by The American Society for Biochemistry and Molecular Biology, Inc.
Ligand-induced
Cleavage of the V Vasopressin Receptor by a Plasma Membrane
Metalloproteinase (*)
(Received for publication, May 18,
1994; and in revised form, January 16, 1995)
Elzbieta
Kojro
,
Falk
Fahrenholz (§)
From the Max-Planck-Institute of Biophysics, Kennedyallee 70,
60596 Frankfurt am Main, Federal Republic of Germany
ABSTRACT
The proteolytic cleavage of a G protein-coupled peptide hormone
receptor, the renal V vasopressin receptor, by a plasma
membrane proteinase was investigated. In the absence of protease
inhibitors during incubation of bovine kidney membranes with a
photoreactive vasopressin agonist, V receptor truncation
leads to a labeled receptor fragment with M 30,000. The V receptor-degrading enzyme could be
completely inhibited by zinc ions yielding the native V receptor glycoprotein with M 58,000. Studies
with inhibitors of metalloendopeptidases involved in peptide hormone
metabolism and with peptide substrates spanning the V receptor cleavage site classify the receptor protease as
metalloendoproteinase with specificity for longer substrates.
Comparison of the NH -terminal protein sequence of the
truncated M 30,000 V receptor with the
sequence deduced from the cDNA of the cloned bovine V
receptor shows that cleavage occurs between Gln and
Val of the second transmembrane helix close to an
extracellular agonist binding site. V receptor proteolysis
was dependent on the presence of a hormonal ligand. It occurred rapidly
after hormone binding and led to a loss of ligand binding properties of
the truncated V receptor. The data suggest that the
endogenous V receptor-degrading metalloendoproteinase
regulates V receptor function. The novel pathway may
contribute to the termination of signal transmission.
FOOTNOTES
- *
- This work
was supported by Grant SFB 169 from the Deutsche
Forschungsgemeinschaft. The costs of publication of this article were
defrayed in part by the payment of page charges. This article must
therefore by hereby marked ``advertisement'' in
accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
- §
- To whom correspondence should be addressed:
Max-PlanckInstitute of Biophysics, Kennedyallee 70, 60596 Frankfurt am
Main, Germany. Tel.: 69-6303-267; Fax: 69-6303-244.
- (
) - The abbreviations used are: HPLC, high
performance liquid chromatography; AEBSF,
4-(2-Aminoethyl)-benzenesulfonyl fluoride hydrochloride; AVP,
[8-arginine] vasopressin; DDAVP, 1- deamino
[8-D-arginine] vasopressin; FAB, fast atom
bombardment; PAGE, polyacrylamide gel electrophoresis; Hepps,
4-(2-hydroxyethyl)-1-piperazinepropanesulfonic acid.
- (
) - Ufer, E., Postina, R., Gorbulev, V., and
Fahrenholz, F.(1995) FEBS Lett, in press.
- (
) - E. Kojro, E. Ufer, and F. Fahrenholz,
unpublished observation.
ACKNOWLEDGEMENTS
x We thank Gaby Horter for invaluable technical
assistance, Dr. Wolfram Schaefer, Max-Planck-Institute of Biochemistry,
Martinsried for mass spectroscopy, Dr. Gerald Gimpl for critically
reading, and Solveigh McCormack and Michael Schwalm for typing the
manuscript.
©1995 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
W. Wei, K. Hackmann, H. Xu, G. Germino, and F. Qian
Characterization of cis-Autoproteolysis of Polycystin-1, the Product of Human Polycystic Kidney Disease 1 Gene
J. Biol. Chem.,
July 27, 2007;
282(30):
21729 - 21737.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. P. Fairfax, J. A. Pitcher, M. G. H. Scott, A. R. Calver, M. N. Pangalos, S. J. Moss, and A. Couve
Phosphorylation and Chronic Agonist Treatment Atypically Modulate GABAB Receptor Cell Surface Stability
J. Biol. Chem.,
March 26, 2004;
279(13):
12565 - 12573.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. Dupre, Z. Chen, C. Le Gouill, C. Theriault, J.-L. Parent, M. Rola-Pleszczynski, and J. Stankova
Trafficking, Ubiquitination, and Down-regulation of the Human Platelet-activating Factor Receptor
J. Biol. Chem.,
November 28, 2003;
278(48):
48228 - 48235.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Grantcharova, J. Furkert, H. P. Reusch, H.-W. Krell, G. Papsdorf, M. Beyermann, R. Schulein, W. Rosenthal, and A. Oksche
The Extracellular N Terminus of the Endothelin B (ETB) Receptor Is Cleaved by a Metalloprotease in an Agonist-dependent Process
J. Biol. Chem.,
November 8, 2002;
277(46):
43933 - 43941.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Zhang, J. Li, J.-G. Li, and L.-Y. Liu-Chen
(-)U50,488H [(trans)-3,4-Dichloro-N-methyl-N-[2-(1-pyrrolidinyl)-cyclohexyl]benzeneacetamide] Induces Internalization and Down-Regulation of the Human, but not the Rat, kappa -Opioid Receptor: Structural Basis for the Differential Regulation
J. Pharmacol. Exp. Ther.,
September 1, 2002;
302(3):
1184 - 1192.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Thibonnier, C. L. Plesnicher, K. Berrada, and L. Berti-Mattera
Role of the human V1 vasopressin receptor COOH terminus in internalization and mitogenic signal transduction
Am J Physiol Endocrinol Metab,
July 1, 2001;
281(1):
E81 - E92.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Jockers, S. Angers, A. Da Silva, P. Benaroch, A. D. Strosberg, M. Bouvier, and S. Marullo
beta 2-Adrenergic Receptor Down-regulation. EVIDENCE FOR A PATHWAY THAT DOES NOT REQUIRE ENDOCYTOSIS
J. Biol. Chem.,
October 8, 1999;
274(41):
28900 - 28908.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Phalipou, R. Seyer, N. Cotte, C. Breton, C. Barberis, M. Hibert, and B. Mouillac
Docking of Linear Peptide Antagonists into the Human V1a Vasopressin Receptor. IDENTIFICATION OF BINDING DOMAINS BY PHOTOAFFINITY LABELING
J. Biol. Chem.,
August 13, 1999;
274(33):
23316 - 23327.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Piedagnel, G. Murphy, P. M. Ronco, and B. Lelongt
Matrix Metalloproteinase 2 (MMP2) and MMP9 Are Produced by Kidney Collecting Duct Principal Cells but Are Differentially Regulated by SV40 Large-T, Arginine Vasopressin, and Epidermal Growth Factor
J. Biol. Chem.,
January 15, 1999;
274(3):
1614 - 1620.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Rapoport, G. D. Chazenbalk, J. C. Jaume, and S. M. McLachlan
The Thyrotropin (TSH)-Releasing Hormone Receptor: Interaction with TSH and Autoantibodies
Endocr. Rev.,
December 1, 1998;
19(6):
673 - 716.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. Phalipou, N. Cotte, E. Carnazzi, R. Seyer, E. Mahe, S. Jard, C. Barberis, and B. Mouillac
Mapping Peptide-binding Domains of the Human V1a Vasopressin Receptor with a Photoactivatable Linear Peptide Antagonist
J. Biol. Chem.,
October 17, 1997;
272(42):
26536 - 26544.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Postina, E. Kojro, and F. Fahrenholz
Separate Agonist and Peptide Antagonist Binding Sites of the Oxytocin Receptor Defined by Their Transfer into the V2 Vasopressin Receptor
J. Biol. Chem.,
December 6, 1996;
271(49):
31593 - 31601.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Takino, H. Sato, A. Shinagawa, and M. Seiki
Identification of the Second Membrane-type Matrix Metalloproteinase (MT-MMP-2) Gene from a Human Placenta cDNA Library
J. Biol. Chem.,
September 29, 1995;
270(39):
23013 - 23020.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A.-L. Matharu, S. J. Mundell, J. L. Benovic, and E. Kelly
Rapid Agonist-induced Desensitization and Internalization of the A2B Adenosine Receptor Is Mediated by a Serine Residue Close to the COOH Terminus
J. Biol. Chem.,
August 3, 2001;
276(32):
30199 - 30207.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. M. Gage, K.-A. Kim, T. T. Cao, and M. von Zastrow
A Transplantable Sorting Signal That Is Sufficient to Mediate Rapid Recycling of G Protein-coupled Receptors
J. Biol. Chem.,
November 21, 2001;
276(48):
44712 - 44720.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1995 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|